Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Laura Caram (Conchas, São Paulo, Brazil), Laura Caram, Renata Ferrari, Duelele Nogueira, Flavia Nogueira, Katina Souza, Nayara Arruda, Mariana Braz, Suzana Tanni, Camila Corrêa, Irma Godoy. Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD). Eur Respir J 2016; 48: Suppl. 60, 3785

Member's Comments

No comment yet.

Related content which might interest you: Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001